# Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America

> **NCT03942497** · — · COMPLETED · sponsor: **Latin American Cooperative Oncology Group** · enrollment: 218 (actual)

## Conditions studied

- Recurrent/Metastatic Urothelial Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03942497
- **Lead sponsor:** Latin American Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2022-02-28
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03942497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03942497, "Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03942497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*